U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. Transparency
  4. FDA-TRACK: Agency-wide Program Performance
  5. FDA-TRACK: User Fee Performance
  1. FDA-TRACK: Agency-wide Program Performance

FDA-TRACK: User Fee Performance


BsUFA

The Biosimilar User Fee Act (BsUFA) authorizes FDA (specifically the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER)) to assess and collect fees for biosimilar biological products. FDA dedicates these fees toward expediting the review process for biosimilar biological products. BsUFA facilitates the development of safe and effective biosimilar products for the American public.


PDUFA

The Prescription Drug User Fee Act (PDUFA) authorizes FDA (specifically the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER)) to assess and collect fees for prescription drug products. FDA dedicates these fees toward expediting the drug development process and the process for the review of human drug applications, including postmarket drug safety activities.

Sign up to receive FDA-TRACK updates

Get regular FDA email updates delivered on this topic to your inbox.